Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,569.71
(
-0.83%
)
US TECH 100
23,589.20
(
-0.87%
)
Dow Jones
45,894.63
(
-0.72%
)
Brent Oil
107.99
(
1.32%
)
Bitcoin
69,351.03
(
-2.65%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 70000

Wednesday, 03/04/2009 4:29:15 AM

Wednesday, March 04, 2009 4:29:15 AM

Post# of 257257
KG and ACUR got a priority review for Acurox, an immediate release oxycodone coformulated with niacin, which is KG's 3rd (in addition to Embeda and Remoxy) pending NDA in the abuse resistance opioids arena.


http://www.reuters.com/article/marketsNews/idINBNG16053120090303?rpc=44
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now